Volume 24, Number 1—January 2018
Research
Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015
Table 3
Indicator | Target | 2012 | 2013 | 2014 | 2015 | 2016 |
---|---|---|---|---|---|---|
AFP cases reported, no. | NA | 186 | 221 | 132 | 113 | 1,298 |
AFP cases with 2 fecal specimens collected within 14 d of onset of paralysis, % | 80 | 92.4 | 92.3 | 95.7 | 71.7 | 89.6 |
Fecal specimens arriving at national level within 3 d of being sent, % | 80 | 83.4 | 87.9 | 87.8 | 79 | 58.8 |
Fecal specimens arriving at laboratory in good condition, % | 90 | 63.7 | 54.6 | 86.4 | 94.3 | 94.2 |
Fecal specimens for which laboratory results were sent within 14 d of receipt at lab, % | 80 | 100 | 100 | 99.2 | 93.1 | 62.5 |
Fecal specimens from which nonpolio enterovirus was isolated, % | 10 | 12.8 | 8.5 | 12.4 | 7.5 | 16.1 |
VDPVs, no. | NA | 0 | 0 | 1 | 12 | 0 |
Sabin virus, no. | NA | 12 | 29 | 1 | 37 | 182 |
*AFP, acute flaccid paralysis; NA, not applicable; VDPV, vaccine-derived poliovirus.
1These authors contributed equally to this article.
Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.